title: Interactions between age, outcome of acute coronary syndromes, and tirofiban therapy.
authors.affiliation: Cardiology Division, Massachusetts General Hospital, Boston, Massachusetts, USA.
authors.forename: James L
authors.initials: JL
authors.lastname: Januzzi
authors.forename: Marc S
authors.initials: MS
authors.lastname: Sabatine
authors.forename: Ying
authors.initials: Y
authors.lastname: Wan
authors.forename: Stephen J
authors.initials: SJ
authors.lastname: Servoss
authors.forename: Peter M
authors.initials: PM
authors.lastname: DiBattiste
authors.forename: I k-Kyung
authors.initials: Ik
authors.lastname: Jang
authors.forename: Pierre
authors.initials: P
authors.lastname: Theroux
mesh_terms: D000328:Adult; D000367:Age Factors; D000368:Aged; D000369:Aged, 80 and over; D000925:Anticoagulants / Q000009:adverse effects / Q000627:therapeutic use*; D003327:Coronary Disease / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy* / Q000401:mortality; D004562:Electrocardiography; D005260:Female; D005343:Fibrinolytic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D006470:Hemorrhage / Q000139:chemically induced*; D006493:Heparin / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D016014:Linear Models; D016015:Logistic Models; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000209:etiology / Q000401:mortality; D018579:Patient Selection; D019039:Platelet Glycoprotein GPIIb-IIIa Complex / Q000037:antagonists & inhibitors*; D011379:Prognosis; D012307:Risk Factors; D012449:Safety; D013997:Time Factors; D000077466:Tirofiban; D016896:Treatment Outcome; D014443:Tyrosine / Q000009:adverse effects / Q000031:analogs & derivatives / Q000627:therapeutic use*
chemical_list: D000925:Anticoagulants; D005343:Fibrinolytic Agents; D019039:Platelet Glycoprotein GPIIb-IIIa Complex; D014443:Tyrosine; D006493:Heparin; D000077466:Tirofiban